TDP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.96699999954753E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.16580000284617E-08 |
Normal-vs-Stage2 |
2.24639999999443E-05 |
Normal-vs-Stage3 |
1.49999999998762E-06 |
Normal-vs-Stage4 |
1.424490E-02 |
Stage1-vs-Stage2 |
6.659900E-02 |
Stage1-vs-Stage3 |
4.043600E-01 |
Stage1-vs-Stage4 |
2.409600E-01 |
Stage2-vs-Stage3 |
4.312800E-01 |
Stage2-vs-Stage4 |
7.011800E-01 |
Stage3-vs-Stage4 |
3.302400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.08149999961316E-07 |
Normal-vs-AfricanAmerican |
1.06819999956542E-07 |
Normal-vs-Asian |
5.167800E-02 |
Caucasian-vs-AfricanAmerican |
2.945000E-01 |
Caucasian-vs-Asian |
3.493000E-01 |
AfricanAmerican-vs-Asian |
4.518200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.42270000003109E-07 |
Normal-vs-Female |
5.803799999482E-07 |
Male-vs-Female |
3.261200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
6.11789999993562E-07 |
Normal-vs-Extreme_Weight |
5.4317999986786E-08 |
Normal-vs-Obese |
2.90929999979817E-07 |
Normal-vs-Extreme_Obese |
4.34949999994494E-06 |
Normal_Weight-vs-Extreme_Weight |
2.400000E-01 |
Normal_Weight-vs-Obese |
7.694200E-01 |
Normal_Weight-vs-Extreme_Obese |
7.412200E-01 |
Extreme_Weight-vs-Obese |
3.744200E-01 |
Extreme_Weight-vs-Extreme_Obese |
7.351600E-01 |
Obese-vs-Extreme_Obese |
8.925800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.00940000030891E-07 |
Normal-vs-Age(41-60Yrs) |
3.7437000000029E-07 |
Normal-vs-Age(61-80Yrs) |
1.6085999998694E-07 |
Normal-vs-Age(81-100Yrs) |
3.31860000035711E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.795200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.428600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.885000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.300800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.372800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.541200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
7.91780000453102E-08 |
Normal-VS-Type2 PRCC |
2.38649999999563E-05 |
Normal-VS-KIRP CIMP |
2.504700E-03 |
Normal-VS-Unclassified PRCC |
2.44379999569944E-08 |
Type1 PRCC-VS-Type2 PRCC |
3.498200E-03 |
Type1 PRCC-VS-KIRP CIMP |
3.909000E-01 |
Type1 PRCC-VS-Unclassified PRCC |
4.030600E-01 |
Type2 PRCC-VS-KIRP CIMP |
5.435200E-01 |
Type2 PRCC-VS-Unclassified PRCC |
1.719140E-03 |
KIRP CIMP-VS-Unclassified PRCC |
1.959980E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.89120000005217E-07 |
Normal-vs-N1 |
9.58250000000493E-05 |
Normal-vs-N2 |
1.661380E-03 |
N0-vs-N1 |
2.945000E-01 |
N0-vs-N2 |
7.646100E-02 |
N1-vs-N2 |
2.566000E-02 |
|
|